ISMPP Highlights
GPP 2022 in Asia Pacific: Translations & Presentations
Since publication of GPP 2022 for company-sponsored research in Annals of Internal Medicine just over one year ago, various presentations have addressed audiences in the Asia Pacific region. ISMPP is also now pleased to announce that translations of GPP 2022 into both Chinese and Japanese are available!
Patients First… at the 19th Annual Meeting!
ISMPP is thrilled to report that 720 attendees gathered at the 19th Annual Meeting of ISMPP, April 24-26, 2023, in Washington, DC – a n! We were also honored that 247, over 40%, were first-time attendees to an ISMPP Annual Meeting! This article shares highlights and photos from the 18th Annual Meeting…
ISMPP Announces Restructure of Its Committees
ISMPP announces a restructure of its committees to better meet the needs of the profession, the Society and our members. The ISMPP Committee Structure will have 4 new pillars that are intended to achieve practice-focused objectives and meet the distinct needs of key segments in the profession…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Copyright Confusion: Demystifying Creative Commons Licenses for Industry-Funded Research
Have you ever published a journal article open access? If so, you might be familiar with Creative Commons (CC) licenses. This series of copyright licenses was designed as an alternative to standard copyright models, allowing authors to retain copyright of their work while setting the conditions for the reuse of the work…
What Is Omnichannel in Medical Communications?
Since the term “omnichannel” first emerged in marketing materials around 2010, its use has expanded across many industries. The early 2020s have seen an explosion in the use of the term “omnichannel” in healthcare, including in medical communications and as an evolution of current medical education planning…
Publications Without Borders – Harmonizing Local and Global Planning
Pharma-sponsored publications add to the evidence base and play a crucial role in various activities, including medical education, medical information, marketing, pricing and market access, and regulatory affairs. They also ensure timeliness of transparent data disclosure. At the local level, publications primarily serve specific needs, such as reimbursement activities, filling evidence gaps, or guiding local clinical practice…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: To Use AI or To Not Use AI…for Manuscript Development?
You are a researcher working on a groundbreaking clinical study that could potentially lead to a significant advancement in the treatment of a complex disease. Some members of the research team want to use artificial intelligence (AI) to develop the first draft of the manuscript. Other team members are concerned about accuracy, interpretation, and potential bias in the content. What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals